2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutationpancreatic acinar cell carcinoma, pancreatic adenosquamous carcinoma, squamous cell carcinoma of pancreasRecruitingPhase 22026-10-08NCT04858334
The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic CancerDigestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pancreatic Carcinoma, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic acinar cell carcinoma, pancreatic adenocarcinoma, pancreatic adenosquamous carcinoma, pancreatic ductal adenocarcinoma, pancreatic neoplasm, squamous cell carcinoma of pancreasActive, not recruitingPhase 2 / Phase 32026-01-07NCT06115499